<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1998-07-15" modified="2017-05-10" version="181">
<accession>Q92841</accession>
<accession>B1AHM0</accession>
<accession>H3BLZ8</accession>
<accession>Q69YT1</accession>
<accession>Q6ICD6</accession>
<name>DDX17_HUMAN</name>
<protein>
<recommendedName>
<fullName>Probable ATP-dependent RNA helicase DDX17</fullName>
<ecNumber>3.6.4.13</ecNumber>
</recommendedName>
<alternativeName>
<fullName>DEAD box protein 17</fullName>
</alternativeName>
<alternativeName>
<fullName>DEAD box protein p72</fullName>
</alternativeName>
<alternativeName>
<fullName evidence="42">DEAD box protein p82</fullName>
</alternativeName>
<alternativeName>
<fullName>RNA-dependent helicase p72</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">DDX17</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1996" name="Nucleic Acids Res." volume="24" first="3739" last="3747">
<title>p72: a human nuclear DEAD box protein highly related to p68.</title>
<authorList>
<person name="Lamm G.M."/>
<person name="Nicol S.M."/>
<person name="Fuller-Pace F.V."/>
<person name="Lamond A.I."/>
</authorList>
<dbReference type="PubMed" id="8871553"/>
<dbReference type="DOI" id="10.1093/nar/24.19.3739"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Genome Biol." volume="5" first="R84.1" last="R84.11">
<title>A genome annotation-driven approach to cloning the human ORFeome.</title>
<authorList>
<person name="Collins J.E."/>
<person name="Wright C.L."/>
<person name="Edwards C.A."/>
<person name="Davis M.P."/>
<person name="Grinham J.A."/>
<person name="Cole C.G."/>
<person name="Goward M.E."/>
<person name="Aguado B."/>
<person name="Mallya M."/>
<person name="Mokrab Y."/>
<person name="Huckle E.J."/>
<person name="Beare D.M."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15461802"/>
<dbReference type="DOI" id="10.1186/gb-2004-5-10-r84"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4)</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3)</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="1999" name="Nature" volume="402" first="489" last="495">
<title>The DNA sequence of human chromosome 22.</title>
<authorList>
<person name="Dunham I."/>
<person name="Hunt A.R."/>
<person name="Collins J.E."/>
<person name="Bruskiewich R."/>
<person name="Beare D.M."/>
<person name="Clamp M."/>
<person name="Smink L.J."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Babbage A.K."/>
<person name="Bagguley C."/>
<person name="Bailey J."/>
<person name="Barlow K.F."/>
<person name="Bates K.N."/>
<person name="Beasley O.P."/>
<person name="Bird C.P."/>
<person name="Blakey S.E."/>
<person name="Bridgeman A.M."/>
<person name="Buck D."/>
<person name="Burgess J."/>
<person name="Burrill W.D."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chen Y."/>
<person name="Clark G."/>
<person name="Clegg S.M."/>
<person name="Cobley V.E."/>
<person name="Cole C.G."/>
<person name="Collier R.E."/>
<person name="Connor R."/>
<person name="Conroy D."/>
<person name="Corby N.R."/>
<person name="Coville G.J."/>
<person name="Cox A.V."/>
<person name="Davis J."/>
<person name="Dawson E."/>
<person name="Dhami P.D."/>
<person name="Dockree C."/>
<person name="Dodsworth S.J."/>
<person name="Durbin R.M."/>
<person name="Ellington A.G."/>
<person name="Evans K.L."/>
<person name="Fey J.M."/>
<person name="Fleming K."/>
<person name="French L."/>
<person name="Garner A.A."/>
<person name="Gilbert J.G.R."/>
<person name="Goward M.E."/>
<person name="Grafham D.V."/>
<person name="Griffiths M.N.D."/>
<person name="Hall C."/>
<person name="Hall R.E."/>
<person name="Hall-Tamlyn G."/>
<person name="Heathcott R.W."/>
<person name="Ho S."/>
<person name="Holmes S."/>
<person name="Hunt S.E."/>
<person name="Jones M.C."/>
<person name="Kershaw J."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Laird G.K."/>
<person name="Langford C.F."/>
<person name="Leversha M.A."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Martyn I.D."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L.H."/>
<person name="Mccann O.T."/>
<person name="Mcclay J."/>
<person name="Mclaren S."/>
<person name="McMurray A.A."/>
<person name="Milne S.A."/>
<person name="Mortimore B.J."/>
<person name="Odell C.N."/>
<person name="Pavitt R."/>
<person name="Pearce A.V."/>
<person name="Pearson D."/>
<person name="Phillimore B.J.C.T."/>
<person name="Phillips S.H."/>
<person name="Plumb R.W."/>
<person name="Ramsay H."/>
<person name="Ramsey Y."/>
<person name="Rogers L."/>
<person name="Ross M.T."/>
<person name="Scott C.E."/>
<person name="Sehra H.K."/>
<person name="Skuce C.D."/>
<person name="Smalley S."/>
<person name="Smith M.L."/>
<person name="Soderlund C."/>
<person name="Spragon L."/>
<person name="Steward C.A."/>
<person name="Sulston J.E."/>
<person name="Swann R.M."/>
<person name="Vaudin M."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="Whiteley M.N."/>
<person name="Willey D.L."/>
<person name="Williams L."/>
<person name="Williams S.A."/>
<person name="Williamson H."/>
<person name="Wilmer T.E."/>
<person name="Wilming L."/>
<person name="Wright C.L."/>
<person name="Hubbard T."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Shimizu N."/>
<person name="Minoshima S."/>
<person name="Kawasaki K."/>
<person name="Sasaki T."/>
<person name="Asakawa S."/>
<person name="Kudoh J."/>
<person name="Shintani A."/>
<person name="Shibuya K."/>
<person name="Yoshizaki Y."/>
<person name="Aoki N."/>
<person name="Mitsuyama S."/>
<person name="Roe B.A."/>
<person name="Chen F."/>
<person name="Chu L."/>
<person name="Crabtree J."/>
<person name="Deschamps S."/>
<person name="Do A."/>
<person name="Do T."/>
<person name="Dorman A."/>
<person name="Fang F."/>
<person name="Fu Y."/>
<person name="Hu P."/>
<person name="Hua A."/>
<person name="Kenton S."/>
<person name="Lai H."/>
<person name="Lao H.I."/>
<person name="Lewis J."/>
<person name="Lewis S."/>
<person name="Lin S.-P."/>
<person name="Loh P."/>
<person name="Malaj E."/>
<person name="Nguyen T."/>
<person name="Pan H."/>
<person name="Phan S."/>
<person name="Qi S."/>
<person name="Qian Y."/>
<person name="Ray L."/>
<person name="Ren Q."/>
<person name="Shaull S."/>
<person name="Sloan D."/>
<person name="Song L."/>
<person name="Wang Q."/>
<person name="Wang Y."/>
<person name="Wang Z."/>
<person name="White J."/>
<person name="Willingham D."/>
<person name="Wu H."/>
<person name="Yao Z."/>
<person name="Zhan M."/>
<person name="Zhang G."/>
<person name="Chissoe S."/>
<person name="Murray J."/>
<person name="Miller N."/>
<person name="Minx P."/>
<person name="Fulton R."/>
<person name="Johnson D."/>
<person name="Bemis G."/>
<person name="Bentley D."/>
<person name="Bradshaw H."/>
<person name="Bourne S."/>
<person name="Cordes M."/>
<person name="Du Z."/>
<person name="Fulton L."/>
<person name="Goela D."/>
<person name="Graves T."/>
<person name="Hawkins J."/>
<person name="Hinds K."/>
<person name="Kemp K."/>
<person name="Latreille P."/>
<person name="Layman D."/>
<person name="Ozersky P."/>
<person name="Rohlfing T."/>
<person name="Scheet P."/>
<person name="Walker C."/>
<person name="Wamsley A."/>
<person name="Wohldmann P."/>
<person name="Pepin K."/>
<person name="Nelson J."/>
<person name="Korf I."/>
<person name="Bedell J.A."/>
<person name="Hillier L.W."/>
<person name="Mardis E."/>
<person name="Waterston R."/>
<person name="Wilson R."/>
<person name="Emanuel B.S."/>
<person name="Shaikh T."/>
<person name="Kurahashi H."/>
<person name="Saitta S."/>
<person name="Budarf M.L."/>
<person name="McDermid H.E."/>
<person name="Johnson A."/>
<person name="Wong A.C.C."/>
<person name="Morrow B.E."/>
<person name="Edelmann L."/>
<person name="Kim U.J."/>
<person name="Shizuya H."/>
<person name="Simon M.I."/>
<person name="Dumanski J.P."/>
<person name="Peyrard M."/>
<person name="Kedra D."/>
<person name="Seroussi E."/>
<person name="Fransson I."/>
<person name="Tapia I."/>
<person name="Bruder C.E."/>
<person name="O'Brien K.P."/>
<person name="Wilkinson P."/>
<person name="Bodenteich A."/>
<person name="Hartman K."/>
<person name="Hu X."/>
<person name="Khan A.S."/>
<person name="Lane L."/>
<person name="Tilahun Y."/>
<person name="Wright H."/>
</authorList>
<dbReference type="PubMed" id="10591208"/>
<dbReference type="DOI" id="10.1038/990031"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Skin</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="2701" last="2721">
<title>Systematic determination of human cyclin dependent kinase (CDK)-9 interactome identifies novel functions in RNA splicing mediated by the DEAD box (DDX)-5/17 RNA helicases.</title>
<authorList>
<person name="Yang J."/>
<person name="Zhao Y."/>
<person name="Kalita M."/>
<person name="Li X."/>
<person name="Jamaluddin M."/>
<person name="Tian B."/>
<person name="Edeh C.B."/>
<person name="Wiktorowicz J.E."/>
<person name="Kudlicki A."/>
<person name="Brasier A.R."/>
</authorList>
<dbReference type="PubMed" id="26209609"/>
<dbReference type="DOI" id="10.1074/mcp.M115.049221"/>
</citation>
<scope>PROTEIN SEQUENCE OF 36-81; 122-154; 210-241; 255-269; 305-313; 365-372; 406-417; 421-428; 458-480; 489-505; 516-528; 536-547; 569-587 AND 671-684</scope>
<scope>INTERACTION WITH CDK9</scope>
<scope>FUNCTION IN ALTERNATIVE SPLICING</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2006" name="Dev. Cell" volume="11" first="547" last="560">
<title>The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation.</title>
<authorList>
<person name="Caretti G."/>
<person name="Schiltz R.L."/>
<person name="Dilworth F.J."/>
<person name="Di Padova M."/>
<person name="Zhao P."/>
<person name="Ogryzko V."/>
<person name="Fuller-Pace F.V."/>
<person name="Hoffman E.P."/>
<person name="Tapscott S.J."/>
<person name="Sartorelli V."/>
</authorList>
<dbReference type="PubMed" id="17011493"/>
<dbReference type="DOI" id="10.1016/j.devcel.2006.08.003"/>
</citation>
<scope>PROTEIN SEQUENCE OF 305-314</scope>
<scope>MASS SPECTROMETRY</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MYOD1</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="1341" last="1352">
<title>A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Yanagisawa J."/>
<person name="Kitagawa H."/>
<person name="Takeyama K."/>
<person name="Ogawa S."/>
<person name="Arao Y."/>
<person name="Suzawa M."/>
<person name="Kobayashi Y."/>
<person name="Yano T."/>
<person name="Yoshikawa H."/>
<person name="Masuhiro Y."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="11250900"/>
<dbReference type="DOI" id="10.1093/emboj/20.6.1341"/>
</citation>
<scope>CAUTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2014" name="EMBO J." volume="33" first="2880" last="2880">
<title>Retraction: 'A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA'.</title>
<authorList>
<person name="Watanabe M."/>
<person name="Yanagisawa J."/>
<person name="Kitagawa H."/>
<person name="Takeyama K."/>
<person name="Ogawa S."/>
<person name="Arao Y."/>
<person name="Suzawa M."/>
<person name="Kobayashi Y."/>
<person name="Yano T."/>
<person name="Yoshikawa H."/>
<person name="Masuhiro Y."/>
<person name="Kato S."/>
</authorList>
<dbReference type="PubMed" id="25452582"/>
<dbReference type="DOI" id="10.15252/embj.201470090"/>
</citation>
<scope>ERRATUM</scope>
<scope>RETRACTION</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="1066" last="1075">
<title>The mRNA of DEAD box protein p72 is alternatively translated into an 82-kDa RNA helicase.</title>
<authorList>
<person name="Uhlmann-Schiffler H."/>
<person name="Rossler O.G."/>
<person name="Stahl H."/>
</authorList>
<dbReference type="PubMed" id="11675387"/>
<dbReference type="DOI" id="10.1074/jbc.M107535200"/>
</citation>
<scope>ALTERNATIVE INITIATION (ISOFORM 1)</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2002" name="Mol. Cell. Biol." volume="22" first="5698" last="5707">
<title>Regulation of alternative splicing by the ATP-dependent DEAD-box RNA helicase p72.</title>
<authorList>
<person name="Hoenig A."/>
<person name="Auboeuf D."/>
<person name="Parker M.M."/>
<person name="O'Malley B.W."/>
<person name="Berget S.M."/>
</authorList>
<dbReference type="PubMed" id="12138182"/>
<dbReference type="DOI" id="10.1128/MCB.22.16.5698-5707.2002"/>
</citation>
<scope>FUNCTION IN ALTERNATIVE SPLICING</scope>
<scope>MUTAGENESIS OF LYS-221; THR-222; ASP-328; TRP-355 AND SER-356</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2003" name="Nucleic Acids Res." volume="31" first="1470" last="1480">
<title>The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells.</title>
<authorList>
<person name="Ogilvie V.C."/>
<person name="Wilson B.J."/>
<person name="Nicol S.M."/>
<person name="Morrice N.A."/>
<person name="Saunders L.R."/>
<person name="Barber G.N."/>
<person name="Fuller-Pace F.V."/>
</authorList>
<dbReference type="PubMed" id="12595555"/>
<dbReference type="DOI" id="10.1093/nar/gkg236"/>
</citation>
<scope>INTERACTION WITH DDX5</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2004" name="BMC Mol. Biol." volume="5" first="11" last="11">
<title>The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner.</title>
<authorList>
<person name="Wilson B.J."/>
<person name="Bates G.J."/>
<person name="Nicol S.M."/>
<person name="Gregory D.J."/>
<person name="Perkins N.D."/>
<person name="Fuller-Pace F.V."/>
</authorList>
<dbReference type="PubMed" id="15298701"/>
<dbReference type="DOI" id="10.1186/1471-2199-5-11"/>
</citation>
<scope>FUNCTION IN TRANSCRIPTIONAL REPRESSION</scope>
<scope>INTERACTION WITH HDAC1</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2004" name="Nature" volume="432" first="235" last="240">
<title>The microprocessor complex mediates the genesis of microRNAs.</title>
<authorList>
<person name="Gregory R.I."/>
<person name="Yan K.-P."/>
<person name="Amuthan G."/>
<person name="Chendrimada T."/>
<person name="Doratotaj B."/>
<person name="Cooch N."/>
<person name="Shiekhattar R."/>
</authorList>
<dbReference type="PubMed" id="15531877"/>
<dbReference type="DOI" id="10.1038/nature03120"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX CONTAINING DROSHA</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2005" name="EMBO J." volume="24" first="543" last="553">
<title>The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor.</title>
<authorList>
<person name="Bates G.J."/>
<person name="Nicol S.M."/>
<person name="Wilson B.J."/>
<person name="Jacobs A.M."/>
<person name="Bourdon J.C."/>
<person name="Wardrop J."/>
<person name="Gregory D.J."/>
<person name="Lane D.P."/>
<person name="Perkins N.D."/>
<person name="Fuller-Pace F.V."/>
</authorList>
<dbReference type="PubMed" id="15660129"/>
<dbReference type="DOI" id="10.1038/sj.emboj.7600550"/>
</citation>
<scope>INTERACTION WITH TP53</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="18">
<citation type="journal article" date="2006" name="Nat. Biotechnol." volume="24" first="1285" last="1292">
<title>A probability-based approach for high-throughput protein phosphorylation analysis and site localization.</title>
<authorList>
<person name="Beausoleil S.A."/>
<person name="Villen J."/>
<person name="Gerber S.A."/>
<person name="Rush J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="16964243"/>
<dbReference type="DOI" id="10.1038/nbt1240"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-523</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="19">
<citation type="journal article" date="2007" name="Cancer Res." volume="67" first="7572" last="7578">
<title>Involvement of RNA helicases p68 and p72 in colon cancer.</title>
<authorList>
<person name="Shin S."/>
<person name="Rossow K.L."/>
<person name="Grande J.P."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="17699760"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-06-4652"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTIONAL COACTIVATOR</scope>
<scope>INTERACTION WITH CTNNB1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2007" name="J. Cell. Biochem." volume="101" first="1252" last="1265">
<title>Concerted activation of the Mdm2 promoter by p72 RNA helicase and the coactivators p300 and P/CAF.</title>
<authorList>
<person name="Shin S."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="17226766"/>
<dbReference type="DOI" id="10.1002/jcb.21250"/>
</citation>
<scope>FUNCTION AS TRANSCRIPTIONAL COACTIVATOR</scope>
<scope>INTERACTION WITH EP300; CREBBP AND KAT2B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-221</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="Nucleic Acids Res." volume="35" first="3590" last="3601">
<title>Redundant role of DEAD box proteins p68 (Ddx5) and p72/p82 (Ddx17) in ribosome biogenesis and cell proliferation.</title>
<authorList>
<person name="Jalal C."/>
<person name="Uhlmann-Schiffler H."/>
<person name="Stahl H."/>
</authorList>
<dbReference type="PubMed" id="17485482"/>
<dbReference type="DOI" id="10.1093/nar/gkm058"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Science" volume="316" first="1160" last="1166">
<title>ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage.</title>
<authorList>
<person name="Matsuoka S."/>
<person name="Ballif B.A."/>
<person name="Smogorzewska A."/>
<person name="McDonald E.R. III"/>
<person name="Hurov K.E."/>
<person name="Luo J."/>
<person name="Bakalarski C.E."/>
<person name="Zhao Z."/>
<person name="Solimini N."/>
<person name="Lerenthal Y."/>
<person name="Shiloh Y."/>
<person name="Gygi S.P."/>
<person name="Elledge S.J."/>
</authorList>
<dbReference type="PubMed" id="17525332"/>
<dbReference type="DOI" id="10.1126/science.1140321"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Embryonic kidney</tissue>
</source>
</reference>
<reference key="23">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="4352" last="4357">
<title>p72 DEAD box RNA helicase is required for optimal function of the zinc-finger antiviral protein.</title>
<authorList>
<person name="Chen G."/>
<person name="Guo X."/>
<person name="Lv F."/>
<person name="Xu Y."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="18334637"/>
<dbReference type="DOI" id="10.1073/pnas.0712276105"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ZC3HAV1; EXOSC3 AND EXOSC5</scope>
<scope>MUTAGENESIS OF LYS-221</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="25">
<citation type="journal article" date="2009" name="Oncogene" volume="28" first="4053" last="4064">
<title>The DEAD-box protein p72 regulates ERalpha-/oestrogen-dependent transcription and cell growth, and is associated with improved survival in ERalpha-positive breast cancer.</title>
<authorList>
<person name="Wortham N.C."/>
<person name="Ahamed E."/>
<person name="Nicol S.M."/>
<person name="Thomas R.S."/>
<person name="Periyasamy M."/>
<person name="Jiang J."/>
<person name="Ochocka A.M."/>
<person name="Shousha S."/>
<person name="Huson L."/>
<person name="Bray S.E."/>
<person name="Coombes R.C."/>
<person name="Ali S."/>
<person name="Fuller-Pace F.V."/>
</authorList>
<dbReference type="PubMed" id="19718048"/>
<dbReference type="DOI" id="10.1038/onc.2009.261"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1</scope>
<scope>MUTAGENESIS OF ASP-325</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2010" name="Biochemistry" volume="49" first="1" last="10">
<title>Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential.</title>
<authorList>
<person name="Mooney S.M."/>
<person name="Grande J.P."/>
<person name="Salisbury J.L."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="19995069"/>
<dbReference type="DOI" id="10.1021/bi901263m"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUMOYLATION AT LYS-129</scope>
<scope>MUTAGENESIS OF LYS-129</scope>
<scope>INTERACTION WITH DDX5; HDAC1; HDAC2; HDAC3; EP300 AND ESR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2010" name="Cancer Res." volume="70" first="3760" last="3770">
<title>Estrogen regulation and physiopathologic significance of alternative promoters in breast cancer.</title>
<authorList>
<person name="Dutertre M."/>
<person name="Gratadou L."/>
<person name="Dardenne E."/>
<person name="Germann S."/>
<person name="Samaan S."/>
<person name="Lidereau R."/>
<person name="Driouch K."/>
<person name="de la Grange P."/>
<person name="Auboeuf D."/>
</authorList>
<dbReference type="PubMed" id="20406972"/>
<dbReference type="DOI" id="10.1158/0008-5472.CAN-09-3988"/>
</citation>
<scope>FUNCTION IN ESTROGEN SIGNALING PATHWAY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="30443" last="30452">
<title>Pleiotropic effects of p300-mediated acetylation on p68 and p72 RNA helicase.</title>
<authorList>
<person name="Mooney S.M."/>
<person name="Goel A."/>
<person name="D'Assoro A.B."/>
<person name="Salisbury J.L."/>
<person name="Janknecht R."/>
</authorList>
<dbReference type="PubMed" id="20663877"/>
<dbReference type="DOI" id="10.1074/jbc.M110.143792"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH ESR1; HDAC1; HDAC2 AND HDAC3</scope>
<scope>ACETYLATION AT LYS-108; LYS-109 AND LYS-121</scope>
<scope>MASS SPECTROMETRY</scope>
<scope>MUTAGENESIS OF 108-LYS-LYS-109 AND LYS-121</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="30">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="15834" last="15839">
<title>Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation.</title>
<authorList>
<person name="Zhu Y."/>
<person name="Chen G."/>
<person name="Lv F."/>
<person name="Wang X."/>
<person name="Ji X."/>
<person name="Xu Y."/>
<person name="Sun J."/>
<person name="Wu L."/>
<person name="Zheng Y.T."/>
<person name="Gao G."/>
</authorList>
<dbReference type="PubMed" id="21876179"/>
<dbReference type="DOI" id="10.1073/pnas.1101676108"/>
</citation>
<scope>INTERACTION WITH DCP1A AND DCP2</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2011" name="Sci. Signal." volume="4" first="RS3" last="RS3">
<title>System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.</title>
<authorList>
<person name="Rigbolt K.T."/>
<person name="Prokhorova T.A."/>
<person name="Akimov V."/>
<person name="Henningsen J."/>
<person name="Johansen P.T."/>
<person name="Kratchmarova I."/>
<person name="Kassem M."/>
<person name="Mann M."/>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
</authorList>
<dbReference type="PubMed" id="21406692"/>
<dbReference type="DOI" id="10.1126/scisignal.2001570"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.013680.01" last="M111.013680.15">
<title>Systematic analysis of protein pools, isoforms, and modifications affecting turnover and subcellular localization.</title>
<authorList>
<person name="Ahmad Y."/>
<person name="Boisvert F.M."/>
<person name="Lundberg E."/>
<person name="Uhlen M."/>
<person name="Lamond A.I."/>
</authorList>
<dbReference type="PubMed" id="22002106"/>
<dbReference type="DOI" id="10.1074/mcp.M111.013680"/>
</citation>
<scope>SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="1139" last="1146">
<title>Splicing switch of an epigenetic regulator by RNA helicases promotes tumor-cell invasiveness.</title>
<authorList>
<person name="Dardenne E."/>
<person name="Pierredon S."/>
<person name="Driouch K."/>
<person name="Gratadou L."/>
<person name="Lacroix-Triki M."/>
<person name="Espinoza M.P."/>
<person name="Zonta E."/>
<person name="Germann S."/>
<person name="Mortada H."/>
<person name="Villemin J.P."/>
<person name="Dutertre M."/>
<person name="Lidereau R."/>
<person name="Vagner S."/>
<person name="Auboeuf D."/>
</authorList>
<dbReference type="PubMed" id="23022728"/>
<dbReference type="DOI" id="10.1038/nsmb.2390"/>
</citation>
<scope>FUNCTION IN ALTERNATIVE SPLICING</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2012" name="Oncogene" volume="31" first="4536" last="4549">
<title>Dual role of the ddx5/ddx17 RNA helicases in the control of the pro-migratory NFAT5 transcription factor.</title>
<authorList>
<person name="Germann S."/>
<person name="Gratadou L."/>
<person name="Zonta E."/>
<person name="Dardenne E."/>
<person name="Gaudineau B."/>
<person name="Fougere M."/>
<person name="Samaan S."/>
<person name="Dutertre M."/>
<person name="Jauliac S."/>
<person name="Auboeuf D."/>
</authorList>
<dbReference type="PubMed" id="22266867"/>
<dbReference type="DOI" id="10.1038/onc.2011.618"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NFAT5</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2013" name="Nucleic Acids Res." volume="41" first="7875" last="7888">
<title>The RNA helicase Ddx5/p68 binds to hUpf3 and enhances NMD of Ddx17/p72 and Smg5 mRNA.</title>
<authorList>
<person name="Geissler V."/>
<person name="Altmeyer S."/>
<person name="Stein B."/>
<person name="Uhlmann-Schiffler H."/>
<person name="Stahl H."/>
</authorList>
<dbReference type="PubMed" id="23788676"/>
<dbReference type="DOI" id="10.1093/nar/gkt538"/>
</citation>
<scope>INTERACTION WITH UPF3B</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2014" name="Biochem. Biophys. Res. Commun." volume="446" first="241" last="247">
<title>Cell cycle-dependent regulation of Aurora kinase B mRNA by the Microprocessor complex.</title>
<authorList>
<person name="Jung E."/>
<person name="Seong Y."/>
<person name="Seo J.H."/>
<person name="Kwon Y.S."/>
<person name="Song H."/>
</authorList>
<dbReference type="PubMed" id="24589731"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2014.02.104"/>
</citation>
<scope>INTERACTION WITH DGCR8</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2014" name="Cell" volume="156" first="893" last="906">
<title>Hippo signaling regulates microprocessor and links cell-density-dependent miRNA biogenesis to cancer.</title>
<authorList>
<person name="Mori M."/>
<person name="Triboulet R."/>
<person name="Mohseni M."/>
<person name="Schlegelmilch K."/>
<person name="Shrestha K."/>
<person name="Camargo F.D."/>
<person name="Gregory R.I."/>
</authorList>
<dbReference type="PubMed" id="24581491"/>
<dbReference type="DOI" id="10.1016/j.cell.2013.12.043"/>
</citation>
<scope>FUNCTION IN MICRORNA MATURATION</scope>
<scope>INTERACTION WITH DROSHA; DGCR8 AND YAP1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF LYS-129</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2014" name="Cell" volume="158" first="764" last="777">
<title>Stem-loop recognition by DDX17 facilitates miRNA processing and antiviral defense.</title>
<authorList>
<person name="Moy R.H."/>
<person name="Cole B.S."/>
<person name="Yasunaga A."/>
<person name="Gold B."/>
<person name="Shankarling G."/>
<person name="Varble A."/>
<person name="Molleston J.M."/>
<person name="tenOever B.R."/>
<person name="Lynch K.W."/>
<person name="Cherry S."/>
</authorList>
<dbReference type="PubMed" id="25126784"/>
<dbReference type="DOI" id="10.1016/j.cell.2014.06.023"/>
</citation>
<scope>FUNCTION IN ANTIVIRAL DEFENSE</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2014" name="Cell Rep." volume="7" first="1900" last="1913">
<title>RNA helicases DDX5 and DDX17 dynamically orchestrate transcription, miRNA, and splicing programs in cell differentiation.</title>
<authorList>
<person name="Dardenne E."/>
<person name="Polay Espinoza M."/>
<person name="Fattet L."/>
<person name="Germann S."/>
<person name="Lambert M.P."/>
<person name="Neil H."/>
<person name="Zonta E."/>
<person name="Mortada H."/>
<person name="Gratadou L."/>
<person name="Deygas M."/>
<person name="Chakrama F.Z."/>
<person name="Samaan S."/>
<person name="Desmet F.O."/>
<person name="Tranchevent L.C."/>
<person name="Dutertre M."/>
<person name="Rimokh R."/>
<person name="Bourgeois C.F."/>
<person name="Auboeuf D."/>
</authorList>
<dbReference type="PubMed" id="24910439"/>
<dbReference type="DOI" id="10.1016/j.celrep.2014.05.010"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HNRNPH1</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-64</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="43">
<citation type="journal article" date="2014" name="Mol. Cell. Proteomics" volume="13" first="372" last="387">
<title>Immunoaffinity enrichment and mass spectrometry analysis of protein methylation.</title>
<authorList>
<person name="Guo A."/>
<person name="Gu H."/>
<person name="Zhou J."/>
<person name="Mulhern D."/>
<person name="Wang Y."/>
<person name="Lee K.A."/>
<person name="Yang V."/>
<person name="Aguiar M."/>
<person name="Kornhauser J."/>
<person name="Jia X."/>
<person name="Ren J."/>
<person name="Beausoleil S.A."/>
<person name="Silva J.C."/>
<person name="Vemulapalli V."/>
<person name="Bedford M.T."/>
<person name="Comb M.J."/>
</authorList>
<dbReference type="PubMed" id="24129315"/>
<dbReference type="DOI" id="10.1074/mcp.O113.027870"/>
</citation>
<scope>METHYLATION [LARGE SCALE ANALYSIS] AT ARG-684</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Colon carcinoma</tissue>
</source>
</reference>
<reference key="44">
<citation type="journal article" date="2014" name="Nat. Struct. Mol. Biol." volume="21" first="927" last="936">
<title>Uncovering global SUMOylation signaling networks in a site-specific manner.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="D'Souza R.C."/>
<person name="Yang B."/>
<person name="Verlaan-de Vries M."/>
<person name="Mann M."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25218447"/>
<dbReference type="DOI" id="10.1038/nsmb.2890"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2014" name="Nucleic Acids Res." volume="42" first="2197" last="2207">
<title>The Ddx5 and Ddx17 RNA helicases are cornerstones in the complex regulatory array of steroid hormone-signaling pathways.</title>
<authorList>
<person name="Samaan S."/>
<person name="Tranchevent L.C."/>
<person name="Dardenne E."/>
<person name="Polay Espinoza M."/>
<person name="Zonta E."/>
<person name="Germann S."/>
<person name="Gratadou L."/>
<person name="Dutertre M."/>
<person name="Auboeuf D."/>
</authorList>
<dbReference type="PubMed" id="24275493"/>
<dbReference type="DOI" id="10.1093/nar/gkt1216"/>
</citation>
<scope>FUNCTION</scope>
<scope>MUTAGENESIS OF LYS-221</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2014" name="Proc. Natl. Acad. Sci. U.S.A." volume="111" first="12432" last="12437">
<title>Mapping of SUMO sites and analysis of SUMOylation changes induced by external stimuli.</title>
<authorList>
<person name="Impens F."/>
<person name="Radoshevich L."/>
<person name="Cossart P."/>
<person name="Ribet D."/>
</authorList>
<dbReference type="PubMed" id="25114211"/>
<dbReference type="DOI" id="10.1073/pnas.1413825111"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2015" name="Cell Rep." volume="10" first="1778" last="1791">
<title>SUMO-2 orchestrates chromatin modifiers in response to DNA damage.</title>
<authorList>
<person name="Hendriks I.A."/>
<person name="Treffers L.W."/>
<person name="Verlaan-de Vries M."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25772364"/>
<dbReference type="DOI" id="10.1016/j.celrep.2015.02.033"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2015" name="Mol. Cell. Proteomics" volume="14" first="1419" last="1434">
<title>System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.</title>
<authorList>
<person name="Xiao Z."/>
<person name="Chang J.G."/>
<person name="Hendriks I.A."/>
<person name="Sigurdsson J.O."/>
<person name="Olsen J.V."/>
<person name="Vertegaal A.C."/>
</authorList>
<dbReference type="PubMed" id="25755297"/>
<dbReference type="DOI" id="10.1074/mcp.O114.044792"/>
</citation>
<scope>SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-129</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2016" name="Biochim. Biophys. Acta" volume="1859" first="1299" last="1305">
<title>The miRNA biogenesis factors, p72/DDX17 and KHSRP regulate the protein level of Ago2 in human cells.</title>
<authorList>
<person name="Connerty P."/>
<person name="Bajan S."/>
<person name="Remenyi J."/>
<person name="Fuller-Pace F.V."/>
<person name="Hutvagner G."/>
</authorList>
<dbReference type="PubMed" id="27478153"/>
<dbReference type="DOI" id="10.1016/j.bbagrm.2016.07.013"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<comment type="function">
<text evidence="9 13 15 18 19 20 21 22 23 24 25 26 29 30 32 33 35 36 37 38 44">As an RNA helicase, unwinds RNA and alters RNA structures through ATP binding and hydrolysis. Involved in multiple cellular processes, including pre-mRNA splicing, alternative splicing, ribosomal RNA processing and miRNA processing, as well as transcription regulation. Regulates the alternative splicing of exons exhibiting specific features (PubMed:12138182, PubMed:23022728, PubMed:24910439, PubMed:22266867). For instance, promotes the inclusion of AC-rich alternative exons in CD44 transcripts (PubMed:12138182). This function requires the RNA helicase activity (PubMed:12138182, PubMed:23022728, PubMed:24910439, PubMed:22266867). Affects NFAT5 and histone macro-H2A.1/H2AFY alternative splicing in a CDK9-dependent manner (PubMed:26209609, PubMed:22266867). In NFAT5, promotes the introduction of alternative exon 4, which contains 2 stop codons and may target NFAT5 exon 4-containing transcripts to nonsense-mediated mRNA decay, leading to the down-regulation of NFAT5 protein (PubMed:22266867). Affects splicing of mediators of steroid hormone signaling pathway, including kinases that phosphorylates ESR1, such as CDK2, MAPK1 and GSK3B, and transcriptional regulators, such as CREBBP, MED1, NCOR1 and NCOR2. By affecting GSK3B splicing, participates in ESR1 and AR stabilization (PubMed:24275493). In myoblasts and epithelial cells, cooperates with HNRNPH1 to control the splicing of specific subsets of exons (PubMed:24910439). In addition to binding mature mRNAs, also interacts with certain pri-microRNAs, including MIR663/miR-663a, MIR99B/miR-99b, and MIR6087/miR-6087 (PubMed:25126784). Binds pri-microRNAs on the 3' segment flanking the stem loop via the 5'-[ACG]CAUC[ACU]-3' consensus sequence (PubMed:24581491). Required for the production of subsets of microRNAs, including MIR21 and MIR125B1 (PubMed:24581491, PubMed:27478153). May be involved not only in microRNA primary transcript processing, but also stabilization (By similarity). Participates in MYC down-regulation at high cell density through the production of MYC-targeting microRNAs (PubMed:24581491). Along with DDX5, may be involved in the processing of the 32S intermediate into the mature 28S ribosomal RNA (PubMed:17485482). Promoter-specific transcription regulator, functioning as a coactivator or corepressor depending on the context of the promoter and the transcriptional complex in which it exists (PubMed:15298701). Enhances NFAT5 transcriptional activity (PubMed:22266867). Synergizes with TP53 in the activation of the MDM2 promoter; this activity requires acetylation on lysine residues (PubMed:17226766, PubMed:20663877, PubMed:19995069). May also coactivate MDM2 transcription through a TP53-independent pathway (PubMed:17226766). Coactivates MMP7 transcription (PubMed:17226766). Along with CTNNB1, coactivates MYC, JUN, FOSL1 and cyclin D1/CCND1 transcription (PubMed:17699760). Alone or in combination with DDX5 and/or SRA1 non-coding RNA, plays a critical role in promoting the assembly of proteins required for the formation of the transcription initiation complex and chromatin remodeling leading to coactivation of MYOD1-dependent transcription. This helicase-independent activity is required for skeletal muscle cells to properly differentiate into myotubes (PubMed:17011493, PubMed:24910439). During epithelial-to-mesenchymal transition, coregulates SMAD-dependent transcriptional activity, directly controlling key effectors of differentiation, including miRNAs which in turn directly repress its expression (PubMed:24910439). Plays a role in estrogen and testosterone signaling pathway at several levels. Mediates the use of alternative promoters in estrogen-responsive genes and regulates transcription and splicing of a large number of steroid hormone target genes (PubMed:24275493, PubMed:20406972, PubMed:20663877, PubMed:19995069). Contrary to splicing regulation activity, transcriptional coregulation of the estrogen receptor ESR1 is helicase-independent (PubMed:19718048, PubMed:24275493). Plays a role in innate immunity. Specifically restricts bunyavirus infection, including Rift Valley fever virus (RVFV) or La Crosse virus (LACV), but not vesicular stomatitis virus (VSV), in an interferon- and DROSHA-independent manner (PubMed:25126784). Binds to RVFV RNA, likely via structured viral RNA elements (PubMed:25126784). Promotes mRNA degradation mediated by the antiviral zinc-finger protein ZC3HAV1, in an ATPase-dependent manner (PubMed:18334637).</text>
</comment>
<comment type="catalytic activity">
<text evidence="39">ATP + H(2)O = ADP + phosphate.</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="39">170 uM for ATP</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 21 22 23 24 26 27 29 31 33 34 35 37">Interacts with DDX5 in an RNA-independent manner (PubMed:12595555, PubMed:19995069). Interacts with CDK9 transcription elongation complex under basal conditions. Following cell stimulation with poly(I:C), a synthetic double-stranded RNA mimicking viral infection, the interaction with CDK9 is decreased (PubMed:26209609). Interacts with ESR1 in an estrogen-independent manner (PubMed:19718048, PubMed:20663877). Interacts with HNRNPH1; this interaction is important for the regulation of alternative splicing on G-quadruplex structures (PubMed:24910439). At high, but not low, cell density, interacts with DROSHA and DGCR8, the core components of the microprocessor complex involved in the maturation of primary microRNAs (pri-miRNAs) into pre-miRNAs. The interaction with DGCR8 is reduced during mitosis (PubMed:24589731, PubMed:24581491). At low, but not high, cell density, interacts with YAP1 and with its paralog, WWTR1/TAZ. Interactions with DROSHA and YAP1 are mutually exclusive (PubMed:24581491). In vitro, the pre-miRNA processing activity of the DDX17-containing microprocessor complex is weaker than that of the DROSHA/DGCR8 microprocessor complex devoid of DDX17 (PubMed:15531877). Interacts with UPF3B (PubMed:23788676). Interacts with NFAT5; this interaction leads to DDX17 recruitment to LNC2 and S100A4 promoters and NFAT5-mediated DDX17-enhanced transactivation (PubMed:22266867). Interacts with HDAC1, HDAC2 and HDAC3; this interaction with HDAC1 and HDAC3, but not HDAC2, depends upon DDX17 acetylation (PubMed:15298701, PubMed:20663877). Interacts with ZC3HAV1 (via N-terminal domain) in an RNA-independent manner. Interacts with EXOSC3/RRP40 and EXOSC5/RRP46; this interaction may be indirect and mediated by ZC3HAV1-binding (PubMed:18334637). Interacts with EP300; this interaction leads to acetylation at lysine residues (PubMed:17226766, PubMed:19995069). Interacts with CREBBP/CBP and KAT2B/P/CAF (PubMed:17226766). Directly interacts with CTNNB1 (PubMed:17699760). Interacts with MYOD1 (PubMed:17011493). Interacts with TP53 (PubMed:15660129). Interacts with DCP1A in an RNA-independent manner. Interacts with DCP2 in an RNA-dependent manner (PubMed:21876179).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-358049">
<id>Q13895</id>
<label>BYSL</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-351962">
<id>P17844</id>
<label>DDX5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-78473">
<id>P03372</id>
<label>ESR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>8</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5280703"/>
<interactant intactId="EBI-301834">
<id>Q13547</id>
<label>HDAC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-739832">
<id>Q8TBB1</id>
<label>LNX1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-81236">
<id>Q15596</id>
<label>NCOA2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-81196">
<id>Q9Y6Q9</id>
<label>NCOA3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-308320">
<id>O94916</id>
<label>NFAT5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-2514922">
<id>Q96T37</id>
<label>RBM15</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-744603">
<id>Q15637</id>
<label>SF1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-6452221">
<id>Q9JKL7</id>
<label>Srek1</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-366083">
<id>P04637</id>
<label>TP53</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-746012"/>
<interactant intactId="EBI-1044059">
<id>P46937</id>
<label>YAP1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 14 19 21 24 28 33 36">Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="19 28">Nucleus</location>
<location evidence="19 28">Nucleolus</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="36">Cytoplasm</location>
<location evidence="36">Cytosol</location>
</subcellularLocation>
<text evidence="36">In the course of bunyavirus infection, relocalizes from the nucleus to the cytosol where it binds viral RNA to antagonize replication.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<event type="alternative initiation"/>
<isoform>
<id>Q92841-4</id>
<name>1</name>
<name>p82</name>
<sequence type="displayed"/>
<text>Starts at an alternative CUG codon.</text>
</isoform>
<isoform>
<id>Q92841-1</id>
<name>2</name>
<name>p72</name>
<sequence type="described" ref="VSP_042527"/>
<text>Produced by alternative initiation at Met-80 of isoform 1.</text>
</isoform>
<isoform>
<id>Q92841-2</id>
<name>3</name>
<sequence type="described" ref="VSP_042527 VSP_042528"/>
<text>Produced by alternative splicing of isoform 2. No experimental confirmation available.</text>
</isoform>
<isoform>
<id>Q92841-3</id>
<name>4</name>
<sequence type="described" ref="VSP_042527 VSP_042529"/>
<text>Produced by alternative splicing of isoform 2. No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="21 39">Widely expressed (PubMed:8871553). Low expression, if any, in normal colonic epithelial cells (at protein level). Levels tend to increase during colon cancer progression, from very low in benign hyperplastic polyps to very high in tubular and villous adenomas (PubMed:17699760).</text>
</comment>
<comment type="PTM">
<text evidence="24">Sumoylation significantly increases stability. It also promotes interaction specifically with HDAC1 (but not HDAC2, nor HDAC3) and strongly stimulates ESR1 and TP53 coactivation.</text>
</comment>
<comment type="PTM">
<text evidence="26">Acetylation at lysine residues stabilizes the protein, stimulates interaction with HDAC1 and HDAC3, but not HDAC2, and represses ESR1 and TP53 coactivation activity.</text>
</comment>
<comment type="similarity">
<text evidence="44">Belongs to the DEAD box helicase family. DDX5/DBP2 subfamily.</text>
</comment>
<comment type="caution">
<text evidence="12 24 25 26 32">Was reported to act as a transcriptional coactivator for estrogen receptor ESR1 (PubMed:11250900). Although this publication was retracted because of aberrations in some figures, this function was also described in other publications by different groups and may be real (PubMed:24275493, PubMed:20406972, PubMed:20663877, PubMed:19995069).</text>
</comment>
<dbReference type="EC" id="3.6.4.13"/>
<dbReference type="EMBL" id="U59321">
<property type="protein sequence ID" value="AAC50787.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CR456432">
<property type="protein sequence ID" value="CAG30318.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL713763">
<property type="protein sequence ID" value="CAH10627.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="Z97056">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471095">
<property type="protein sequence ID" value="EAW60243.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC000595">
<property type="protein sequence ID" value="AAH00595.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS33646.1">
<molecule id="Q92841-4"/>
</dbReference>
<dbReference type="PIR" id="S72367">
<property type="entry name" value="S72367"/>
</dbReference>
<dbReference type="RefSeq" id="NP_006377.2">
<molecule id="Q92841-4"/>
<property type="nucleotide sequence ID" value="NM_006386.4"/>
</dbReference>
<dbReference type="UniGene" id="Hs.528305"/>
<dbReference type="UniGene" id="Hs.706116"/>
<dbReference type="ProteinModelPortal" id="Q92841"/>
<dbReference type="SMR" id="Q92841"/>
<dbReference type="BioGrid" id="115776">
<property type="interactions" value="155"/>
</dbReference>
<dbReference type="DIP" id="DIP-29843N"/>
<dbReference type="IntAct" id="Q92841">
<property type="interactions" value="82"/>
</dbReference>
<dbReference type="MINT" id="MINT-4545892"/>
<dbReference type="STRING" id="9606.ENSP00000380033"/>
<dbReference type="iPTMnet" id="Q92841"/>
<dbReference type="PhosphoSitePlus" id="Q92841"/>
<dbReference type="SwissPalm" id="Q92841"/>
<dbReference type="BioMuta" id="DDX17"/>
<dbReference type="REPRODUCTION-2DPAGE" id="IPI00023785"/>
<dbReference type="EPD" id="Q92841"/>
<dbReference type="MaxQB" id="Q92841"/>
<dbReference type="PaxDb" id="Q92841"/>
<dbReference type="PeptideAtlas" id="Q92841"/>
<dbReference type="PRIDE" id="Q92841"/>
<dbReference type="TopDownProteomics" id="Q92841-1">
<molecule id="Q92841-1"/>
</dbReference>
<dbReference type="TopDownProteomics" id="Q92841-4">
<molecule id="Q92841-4"/>
</dbReference>
<dbReference type="DNASU" id="10521"/>
<dbReference type="Ensembl" id="ENST00000403230">
<property type="protein sequence ID" value="ENSP00000385536"/>
<property type="gene ID" value="ENSG00000100201"/>
</dbReference>
<dbReference type="GeneID" id="10521"/>
<dbReference type="KEGG" id="hsa:10521"/>
<dbReference type="UCSC" id="uc062efu.1">
<molecule id="Q92841-4"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="10521"/>
<dbReference type="DisGeNET" id="10521"/>
<dbReference type="GeneCards" id="DDX17"/>
<dbReference type="HGNC" id="HGNC:2740">
<property type="gene designation" value="DDX17"/>
</dbReference>
<dbReference type="HPA" id="CAB024908"/>
<dbReference type="HPA" id="HPA063142"/>
<dbReference type="MIM" id="608469">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q92841"/>
<dbReference type="PharmGKB" id="PA27206"/>
<dbReference type="eggNOG" id="KOG0331">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="COG0513">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="HOGENOM" id="HOG000268804"/>
<dbReference type="HOVERGEN" id="HBG015893"/>
<dbReference type="InParanoid" id="Q92841"/>
<dbReference type="KO" id="K13178"/>
<dbReference type="SIGNOR" id="Q92841"/>
<dbReference type="ChiTaRS" id="DDX17">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="DDX17"/>
<dbReference type="GenomeRNAi" id="10521"/>
<dbReference type="PRO" id="PR:Q92841"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 22"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000100201"/>
<dbReference type="CleanEx" id="HS_DDX17"/>
<dbReference type="ExpressionAtlas" id="Q92841">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q92841">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016607">
<property type="term" value="C:nuclear speck"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0004004">
<property type="term" value="F:ATP-dependent RNA helicase activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0030331">
<property type="term" value="F:estrogen receptor binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003724">
<property type="term" value="F:RNA helicase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0008186">
<property type="term" value="F:RNA-dependent ATPase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003713">
<property type="term" value="F:transcription coactivator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000380">
<property type="term" value="P:alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030521">
<property type="term" value="P:androgen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0001837">
<property type="term" value="P:epithelial to mesenchymal transition"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031047">
<property type="term" value="P:gene silencing by RNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030520">
<property type="term" value="P:intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010586">
<property type="term" value="P:miRNA metabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045445">
<property type="term" value="P:myoblast differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033148">
<property type="term" value="P:positive regulation of intracellular estrogen receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000381">
<property type="term" value="P:regulation of alternative mRNA splicing, via spliceosome"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2001014">
<property type="term" value="P:regulation of skeletal muscle cell differentiation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006357">
<property type="term" value="P:regulation of transcription from RNA polymerase II promoter"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006396">
<property type="term" value="P:RNA processing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0010501">
<property type="term" value="P:RNA secondary structure unwinding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006364">
<property type="term" value="P:rRNA processing"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="InterPro" id="IPR011545">
<property type="entry name" value="DEAD/DEAH_box_helicase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR014001">
<property type="entry name" value="Helicase_ATP-bd"/>
</dbReference>
<dbReference type="InterPro" id="IPR001650">
<property type="entry name" value="Helicase_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR027417">
<property type="entry name" value="P-loop_NTPase"/>
</dbReference>
<dbReference type="InterPro" id="IPR000629">
<property type="entry name" value="RNA-helicase_DEAD-box_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR014014">
<property type="entry name" value="RNA_helicase_DEAD_Q_motif"/>
</dbReference>
<dbReference type="Pfam" id="PF00270">
<property type="entry name" value="DEAD"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00271">
<property type="entry name" value="Helicase_C"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00487">
<property type="entry name" value="DEXDc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00490">
<property type="entry name" value="HELICc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52540">
<property type="entry name" value="SSF52540"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00039">
<property type="entry name" value="DEAD_ATP_HELICASE"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51192">
<property type="entry name" value="HELICASE_ATP_BIND_1"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51194">
<property type="entry name" value="HELICASE_CTER"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS51195">
<property type="entry name" value="Q_MOTIF"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0024">Alternative initiation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0347">Helicase</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0488">Methylation</keyword>
<keyword id="KW-0507">mRNA processing</keyword>
<keyword id="KW-0508">mRNA splicing</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0943">RNA-mediated gene silencing</keyword>
<keyword id="KW-0698">rRNA processing</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="chain" description="Probable ATP-dependent RNA helicase DDX17" id="PRO_0000054993">
<location>
<begin position="1"/>
<end position="729"/>
</location>
</feature>
<feature type="domain" description="Helicase ATP-binding" evidence="10">
<location>
<begin position="202"/>
<end position="377"/>
</location>
</feature>
<feature type="domain" description="Helicase C-terminal" evidence="11">
<location>
<begin position="405"/>
<end position="552"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="10">
<location>
<begin position="215"/>
<end position="222"/>
</location>
</feature>
<feature type="region of interest" description="Transactivation domain">
<location>
<begin position="547"/>
<end position="729"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with YAP1" evidence="33">
<location>
<begin position="718"/>
<end position="726"/>
</location>
</feature>
<feature type="short sequence motif" description="Q motif">
<location>
<begin position="171"/>
<end position="199"/>
</location>
</feature>
<feature type="short sequence motif" description="DEAD box">
<location>
<begin position="325"/>
<end position="328"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="101"/>
<end position="104"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Gly">
<location>
<begin position="556"/>
<end position="563"/>
</location>
</feature>
<feature type="compositionally biased region" description="Poly-Pro">
<location>
<begin position="718"/>
<end position="726"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="2 4">
<location>
<position position="64"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="26">
<location>
<position position="108"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="26">
<location>
<position position="109"/>
</location>
</feature>
<feature type="modified residue" description="N6-acetyllysine; by EP300" evidence="26">
<location>
<position position="121"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="1">
<location>
<position position="523"/>
</location>
</feature>
<feature type="modified residue" description="Omega-N-methylarginine" evidence="3">
<location>
<position position="684"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO); alternate">
<location>
<position position="129"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO1); alternate" evidence="5 24">
<location>
<position position="129"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO2); alternate" evidence="6 7 8">
<location>
<position position="129"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2, isoform 3 and isoform 4." id="VSP_042527" evidence="40 41 43">
<location>
<begin position="1"/>
<end position="79"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_042528" evidence="41">
<original>L</original>
<variation>LGL</variation>
<location>
<position position="482"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_042529" evidence="40">
<original>G</original>
<variation>GKG</variation>
<location>
<position position="562"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HDAC1-, HDAC2- nor HDAC3-binding, small decrease in ESR1 coactivation, decreased TP53 coactivation. Complete loss of lysine acetylation, decreased stability, loss of ESR1 and TP53 coactivation and loss of HDAC1- and HDAC3-binding, no effect on HDAC2-binding; when associated with R-121." evidence="26">
<original>KK</original>
<variation>RR</variation>
<location>
<begin position="108"/>
<end position="109"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on HDAC1-, HDAC2- nor HDAC3-binding, decreased ESR1 coactivation, strongly decreased TP53 coactivation. Complete loss of lysine acetylation, decreased stability, loss of ESR1 and TP53 coactivation and loss of HDAC1- and HDAC3-binding, no effect on HDAC2-binding; when associated with 108-R-R-109." evidence="26">
<original>K</original>
<variation>R</variation>
<location>
<position position="121"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impaired sumoylation and decreased stability. Impairs interaction with HDAC1, but not with HDAC2, nor HDAC3. No effect on EP300-, ESR1-, DDX5- and YAP1-binding." evidence="24 33">
<original>K</original>
<variation>R</variation>
<location>
<position position="129"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on transcription activation, when assayed in luciferase reporter gene assays using MDM2 or FOS promoters, either alone or in the presence of EP300 and KAT2B." evidence="19">
<original>K</original>
<variation>N</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of helicase activity. Loss of splicing regulation in the estrogen signaling pathway. Reduced CD44 alternative splicing regulation. Does not promote ZCH3HAV1-mediated RNA degradation." evidence="13 22 32">
<original>K</original>
<variation>R</variation>
<location>
<position position="221"/>
</location>
</feature>
<feature type="mutagenesis site" description="Decreased CD44 alternative splicing." evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="222"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of helicase activity. No effect on ESR1 coactivation." evidence="23">
<original>D</original>
<variation>N</variation>
<location>
<position position="325"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small decrease in CD44 alternative splicing." evidence="13">
<original>D</original>
<variation>H</variation>
<location>
<position position="328"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small decrease in CD44 alternative splicing." evidence="13">
<original>W</original>
<variation>G</variation>
<location>
<position position="355"/>
</location>
</feature>
<feature type="mutagenesis site" description="Small decrease in CD44 alternative splicing." evidence="13">
<original>S</original>
<variation>L</variation>
<location>
<position position="356"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="16964243"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24129315"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25114211"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25218447"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25755297"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="25772364"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q501J6"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00541"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00542"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11250900"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12138182"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12595555"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15298701"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15531877"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15660129"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17011493"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17226766"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17485482"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17699760"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18334637"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19718048"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19995069"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20406972"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20663877"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21876179"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22002106"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22266867"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23022728"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23788676"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24275493"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24581491"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24589731"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24910439"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25126784"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26209609"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27478153"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8871553"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15461802"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="17974005"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="19995069"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="8871553"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000305"/>
<sequence length="729" mass="80272" checksum="C819F53515B1BC39" modified="2012-03-21" version="2">
MPTGFVAPILCVLLPSPTREAATVASATGDSASERESAAPAAAPTAEAPPPSVVTRPEPQ
ALPSPAIRAPLPDLYPFGTMRGGGFGDRDRDRDRGGFGARGGGGLPPKKFGNPGERLRKK
KWDLSELPKFEKNFYVEHPEVARLTPYEVDELRRKKEITVRGGDVCPKPVFAFHHANFPQ
YVMDVLMDQHFTEPTPIQCQGFPLALSGRDMVGIAQTGSGKTLAYLLPAIVHINHQPYLE
RGDGPICLVLAPTRELAQQVQQVADDYGKCSRLKSTCIYGGAPKGPQIRDLERGVEICIA
TPGRLIDFLESGKTNLRRCTYLVLDEADRMLDMGFEPQIRKIVDQIRPDRQTLMWSATWP
KEVRQLAEDFLRDYTQINVGNLELSANHNILQIVDVCMESEKDHKLIQLMEEIMAEKENK
TIIFVETKRRCDDLTRRMRRDGWPAMCIHGDKSQPERDWVLNEFRSGKAPILIATDVASR
GLDVEDVKFVINYDYPNSSEDYVHRIGRTARSTNKGTAYTFFTPGNLKQARELIKVLEEA
NQAINPKLMQLVDHRGGGGGGGGRSRYRTTSSANNPNLMYQDECDRRLRGVKDGGRRDSA
SYRDRSETDRAGYANGSGYGSPNSAFGAQAGQYTYGQGTYGAAAYGTSSYTAQEYGAGTY
GASSTTSTGRSSQSSSQQFSGIGRSGQQPQPLMSQQFAQPPGATNMIGYMGQTAYQYPPP
PPPPPPSRK
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>